D. Santos García

发表

Impact of Coronavirus Disease 2019 Pandemic on Parkinson's Disease: A Cross‐Sectional Survey of 568 Spanish Patients

D. Santos-García, D. Santos García, M. Oreiro, 2020, Movement disorders : official journal of the Movement Disorder Society.

Safinamide Improves Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

R. Yáñez Baña, M. G. Alonso Losada, D. Santos García, 2021, Brain sciences.

Falls Predict Acute Hospitalization in Parkinson’s Disease

J. Kulisevsky, P. Martínez-Martín, P. Pástor, 2021, Journal of Parkinson's disease.

Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study

C. Labandeira, R. Yáñez Baña, M. G. Alonso Losada, 2022, Brain sciences.

Genome Analysis of Haplotype D of Candidatus Liberibacter Solanacearum

Shiri Freilich, L. Katsir, Jiandong Jiang, 2018, Front. Microbiol..

Constipation Predicts Cognitive Decline in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-up and Comparison with a Control Group.

J. Kulisevsky, P. Martínez-Martín, P. Pástor, 2021, Journal of Parkinson's disease.

Complete Assembly of the Genome of an Acidovorax citrulli Strain Reveals a Naturally Occurring Plasmid in This Species

Inbar Plaschkes, S. Morin, S. Burdman, 2019, Front. Microbiol..

Predictors of clinically significant quality of life impairment in Parkinson’s disease

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2021, npj Parkinson's Disease.

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort.

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2019, Parkinsonism & related disorders.

Predictors of Loss of Functional Independence in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up and Comparison with a Control Group

J. Kulisevsky, P. Martínez-Martín, P. Pástor, 2021, Diagnostics.

The impact of freezing of gait on functional dependency in Parkinson’s disease with regard to motor phenotype

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2020, Neurological Sciences.

Inter-rater variability in motor function assessment in Parkinson's disease between experts in movement disorders and nurses specialising in PD management.

D. Santos García, T. de Deus Fonticoba, M. Macías Arribí, 2017, Neurologia.

Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson’s Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

J. Kulisevsky, P. Martínez-Martín, P. Pástor, 2021, Diagnostics.

Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson’s Disease: An Open-Label Prospective Study

F. Escamilla Sevilla, D. Santos García, Juan Manuel Oropesa-Ruiz, 2022, Brain sciences.

Staging Parkinson's Disease Combining Motor and Nonmotor Symptoms Correlates with Disability and Quality of Life

J. Kulisevsky, P. Martínez-Martín, P. Pástor, 2021, Parkinson's Disease.

COPPADIS‐2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation

I. Parees, J. Kulisevsky, P. Martínez-Martín, 2019, European journal of neurology.

MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice

J. Kulisevsky, M. Luquin, P. Martínez-Martín, 2021, Diagnostics.

Effectiveness of Safinamide over Mood in Parkinson’s Disease Patients: Secondary Analysis of the Open-label Study SAFINONMOTOR

C. Labandeira, R. Yáñez Baña, M. G. Alonso Losada, 2021, Advances in Therapy.

Safinamide improves sleep and daytime sleepiness in Parkinson’s disease: results from the SAFINONMOTOR study

R. Yáñez Baña, M. G. Alonso Losada, D. Santos García, 2021, Neurological Sciences.

Pain Improvement in Parkinson’s Disease Patients Treated with Safinamide: Results from the SAFINONMOTOR Study

R. Yáñez Baña, M. G. Alonso Losada, D. Santos García, 2021, Journal of personalized medicine.

Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations.

P. Mir, F. Escamilla Sevilla, P. G. Garcia Ruiz, 2023, Neurologia.

Using network analysis to explore the validity and influential items of the Parkinson’s Disease Questionnaire-39

T. Prell, P. Mir, Jianjun Wu, 2023, Scientific reports.

Multiple cranial neuropathy associated with herpes simplex virus infection and anti-GM2 immunoglobulin M antibodies.

R. de la Fuente-Fernández, D. Santos García, M. Llaneza, 2009, Journal of clinical neuromuscular disease.

Clinical management of patients with advanced Parkinson's disease treated with continuous intestinal infusion of levodopa/carbidopa.

A. Seoane Urgorri, V. Puente Périz, J. C. Martínez Castrillo, 2016, Neurodegenerative disease management.

Inter-rater variability in motor function assessment in Parkinson's disease between experts in movement disorders and nurses specialising in PD management.

T. de Deus Fonticoba, D. Santos García, M. Macías Arribí, 2017, Neurologia.

Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project

J. Kulisevsky, F. Valldeoriola, M. Luquin, 2021, Brain sciences.